Works by Sugawara, Shunichi

Results: 68
    1

    Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.

    Published in:
    2017
    By:
    • Shinjiro Sakamoto;
    • Teppei Yamada;
    • Yasuhiro Terazaki;
    • Koichi Yoshiyama;
    • Shunichi Sugawara;
    • Shinzo Takamori;
    • Satoko Matsueda;
    • Shigeki Shichijo;
    • Akira Yamada;
    • Masanori Noguchi;
    • Kyogo Itoh;
    • Noboru Hattori;
    • Nobuoki Kohno;
    • Tetsuro Sasada;
    • Sakamoto, Shinjiro;
    • Yamada, Teppei;
    • Terazaki, Yasuhiro;
    • Yoshiyama, Koichi;
    • Sugawara, Shunichi;
    • Takamori, Shinzo
    Publication type:
    journal article
    2
    3
    4
    5

    Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e536, doi. 10.1634/theoncologist.2019-0550
    By:
    • Aso, Mari;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Ogasawara, Takahiro;
    • Tsurumi, Kyoji;
    • Ono, Kana;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    6

    Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1358, doi. 10.1634/theoncologist.2017-0384
    By:
    • Toi, Yukihiro;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Tsurumi, Kyoji;
    • Suzuki, Kana;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Ono, Hirotaka;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro
    Publication type:
    Article
    7
    8

    Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials.

    Published in:
    Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2017.00972
    By:
    • Harada, Toshiyuki;
    • Amano, Toraji;
    • Ikari, Tomoo;
    • Takamura, Kei;
    • Ogi, Takahiro;
    • Fujikane, Toshiaki;
    • Fujita, Yuka;
    • Taima, Kageaki;
    • Tanaka, Hisashi;
    • Sasaki, Takaaki;
    • Okumura, Shunsuke;
    • Sugawara, Shunichi;
    • Yokouchi, Hiroshi;
    • Yamada, Noriyuki;
    • Morikawa, Naoto;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    9
    10
    11

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    12
    13

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    14

    ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer.

    Published in:
    Cancer Science, 2018, v. 109, n. 8, p. 2532, doi. 10.1111/cas.13651
    By:
    • Azuma, Koichi;
    • Nishio, Makoto;
    • Hayashi, Hidetoshi;
    • Kiura, Katsuyuki;
    • Satouchi, Miyako;
    • Sugawara, Shunichi;
    • Hida, Toyoaki;
    • Iwamoto, Yasuo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Ikeda, Satoshi;
    • Nakagawa, Tomoki;
    • Takeda, Kentaro;
    • Asahina, Seitaro;
    • Komatsu, Kanji;
    • Morita, Satoshi;
    • Fukuoka, Masahiro;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    15
    16

    Accumulation of p62/ SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma.

    Published in:
    Cancer Science, 2012, v. 103, n. 4, p. 760, doi. 10.1111/j.1349-7006.2012.02216.x
    By:
    • Inoue, Daisuke;
    • Suzuki, Takashi;
    • Mitsuishi, Yoichiro;
    • Miki, Yasuhiro;
    • Suzuki, Satoshi;
    • Sugawara, Shunichi;
    • Watanabe, Mika;
    • Sakurada, Akira;
    • Endo, Chiaki;
    • Uruno, Akira;
    • Sasano, Hironobu;
    • Nakagawa, Takayuki;
    • Satoh, Kennichi;
    • Tanaka, Nobuyuki;
    • Kubo, Hiroshi;
    • Motohashi, Hozumi;
    • Yamamoto, Masayuki
    Publication type:
    Article
    17
    18

    Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 352, doi. 10.1634/theoncologist.2013-0411
    By:
    • Maemondo, Makoto;
    • Inoue, Akira;
    • Sugawara, Shunichi;
    • Harada, Toshiyuki;
    • Minegishi, Yuji;
    • Usui, Kazuhiro;
    • Miwa, Koji;
    • Morikawa, Naoto;
    • Kambe, Mariko;
    • Ube, Kenji;
    • Watanabe, Kana;
    • Ishimoto, Osamu;
    • Sakakibara, Tomohiro;
    • Gemma, Akihiko;
    • Nukiwa, Toshihiro
    Publication type:
    Article
    19

    A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901.

    Published in:
    Oncologist, 2013, v. 18, n. 4, p. 439, doi. 10.1634/theoncologist.2012-0308
    By:
    • Harada, Toshiyuki;
    • Oizumi, Satoshi;
    • Ito, Kenichiro;
    • Takamura, Kei;
    • Kikuchi, Eiki;
    • Kuda, Tomoya;
    • Sugawara, Shunichi;
    • Suzuki, Aya;
    • Maemondo, Makoto;
    • Fujita, Yuka;
    • Kinoshita, Ichiro;
    • Inoue, Akira;
    • Hommura, Fumihiro;
    • Katsuura, Yutaka;
    • Dosaka‐Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    20

    Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.

    Published in:
    2012
    By:
    • Oizumi, Satoshi;
    • Kobayashi, Kunihiko;
    • Inoue, Akira;
    • Maemondo, Makoto;
    • Sugawara, Shunichi;
    • Yoshizawa, Hirohisa;
    • Isobe, Hiroshi;
    • Harada, Masao;
    • Kinoshita, Ichiro;
    • Okinaga, Shoji;
    • Kato, Terufumi;
    • Harada, Toshiyuki;
    • Gemma, Akihiko;
    • Saijo, Yasuo;
    • Yokomizo, Yuki;
    • Morita, Satoshi;
    • Hagiwara, Koichi;
    • Nukiwa, Toshihiro
    Publication type:
    Journal Article
    21

    Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.

    Published in:
    Oncologist, 2012, v. 17, n. 6, p. 863, doi. 10.1634/theoncologist.2011-0426
    By:
    • OIZUMI, SATOSHI;
    • KOBAYASHI, KUNIHIKO;
    • INOUE, AKIRA;
    • MAEMONDO, MAKOTO;
    • SUGAWARA, SHUNICHI;
    • YOSHIZAWA, HIROHISA;
    • ISOBE, HIROSHI;
    • HARADA, MASAO;
    • KINOSHITA, ICHIRO;
    • OKINAGA, SHOJI;
    • KATO, TERUFUMI;
    • HARADA, TOSHIYUKI;
    • GEMMA, AKIHIKO;
    • SAIJO, YASUO;
    • YOKOMIZO, YUKI;
    • MORITA, SATOSHI;
    • HAGIWARA, KOICHI;
    • NUKIWA, TOSHIHIRO
    Publication type:
    Article
    22
    23
    24
    25

    Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.

    Published in:
    International Journal of Oncology, 2020, v. 56, n. 6, p. 1479, doi. 10.3892/ijo.2020.5019
    By:
    • Suekane, Shigetaka;
    • Yutani, Shigeru;
    • Yamada, Akira;
    • Sasada, Tetsuro;
    • Matsueda, Satoko;
    • Takamori, Shinzo;
    • Toh, Uhi;
    • Kawano, Kouichiro;
    • Yoshiyama, Koichi;
    • Sakamoto, Shinjiro;
    • Sugawara, Shunichi;
    • Komatsu, Nobukazu;
    • Yamada, Teppei;
    • Naito, Masayasu;
    • Terasaki, Mizuhiko;
    • Mine, Takashi;
    • Itoh, Kyogo;
    • Shichijo, Shigeki;
    • Noguchi, Masanori
    Publication type:
    Article
    26

    Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.

    Published in:
    International Journal of Oncology, 2015, v. 46, n. 1, p. 55, doi. 10.3892/ijo.2014.2699
    By:
    • TEPPEI YAMADA;
    • YASUHIRO TERAZAKI;
    • SHINJIRO SAKAMOTO;
    • KOICHI YOSHIYAMA;
    • SATOKO MATSUEDA;
    • NOBUKAZU KOMATSU;
    • KAYOKO WAKI;
    • AKIRA YAMADA;
    • AKIHIKO KAWAHARA;
    • MASAYOSHI KAGE;
    • SHUNICHI SUGAWARA;
    • YUICHI YAMASHITA;
    • TETSURO SASADA;
    • SHINZO TAKAMORI;
    • KYOGO ITOH
    Publication type:
    Article
    27
    28

    Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z
    By:
    • Sugawara, Shunichi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Nokihara, Hiroshi;
    • Ohe, Yuichiro;
    • Nishio, Makoto;
    • Takahashi, Toshiaki;
    • Goto, Koichi;
    • Maemondo, Makoto;
    • Ichinose, Yukito;
    • Seto, Takashi;
    • Sakai, Hiroshi;
    • Gemma, Akihiko;
    • Imamura, Fumio;
    • Shingyoji, Masato;
    • Saka, Hideo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Okamoto, Isamu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    29
    30
    31

    A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016).

    Published in:
    Investigational New Drugs, 2017, v. 35, n. 2, p. 227, doi. 10.1007/s10637-017-0436-1
    By:
    • Miura, Satoru;
    • Maemondo, Makoto;
    • Iwashima, Akira;
    • Harada, Toshiyuki;
    • Sugawara, Shunichi;
    • Kobayashi, Kunihiko;
    • Inoue, Akira;
    • Nakagawa, Taku;
    • Takiguchi, Yuichi;
    • Watanabe, Hiroshi;
    • Ishida, Takashi;
    • Terada, Masaki;
    • Kagamu, Hiroshi;
    • Gemma, Akihiko;
    • Yoshizawa, Hirohisa
    Publication type:
    Article
    32

    Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

    Published in:
    2020
    By:
    • Naqash, Abdul Rafeh;
    • Ricciuti, Biagio;
    • Owen, Dwight H.;
    • Florou, Vaia;
    • Toi, Yukihiro;
    • Cherry, Cynthia;
    • Hafiz, Maida;
    • De Giglio, Andrea;
    • Muzaffar, Mavish;
    • Patel, Sandip H.;
    • Sugawara, Shunichi;
    • Burkart, Jarred;
    • Park, Wungki;
    • Chiari, Rita;
    • Sugisaka, Jun;
    • Otterson, Gregory A.;
    • de Lima Lopes, Gilberto;
    • Walker, Paul R.
    Publication type:
    Correction Notice
    33

    Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1177, doi. 10.1007/s00262-020-02536-5
    By:
    • Naqash, Abdul Rafeh;
    • Ricciuti, Biagio;
    • Owen, Dwight H.;
    • Florou, Vaia;
    • Toi, Yukihiro;
    • Cherry, Cynthia;
    • Hafiz, Maida;
    • De Giglio, Andrea;
    • Muzaffar, Mavish;
    • Patel, Sandip H.;
    • Sugawara, Shunichi;
    • Burkart, Jarred;
    • Park, Wungki;
    • Chiari, Rita;
    • Sugisaka, Jun;
    • Otterson, Gregory A.;
    • de Lima Lopes, Gilberto;
    • Walker, Paul R.
    Publication type:
    Article
    34

    A Phase II Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q).

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 1, p. 85, doi. 10.1016/j.cllc.2023.09.006
    By:
    • Shinji Nakamichi;
    • Kaoru Kubota;
    • Kotone Matsuyama;
    • Toshihiro Misumi;
    • Toshiyuki Kozuki;
    • Shunichi Sugawara;
    • Katsuhiko Naoki;
    • Nobuaki Kobayashi;
    • Takehito Shukuya;
    • Tsuneo Shimokawa;
    • Masashi Ishihara;
    • Hiroshi Wakui;
    • Yukio Hosomi;
    • Hiroshi Tanaka;
    • Haruhiro Saito;
    • Shinobu Hosokawa;
    • Yuichi Takiguchi;
    • Takashi Kasai;
    • Hiroshi Nokihara;
    • Ryo Morita
    Publication type:
    Article
    35

    A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non--Small Cell Lung Cancer Study: (NEJ048A/NEXUS).

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 4, p. 371, doi. 10.1016/j.cllc.2023.01.008
    By:
    • Akihiko Miyanaga;
    • Hajime Asahina;
    • Satoshi Watanabe;
    • Takehito Shukuya;
    • Yukari Tsubata;
    • Yukio Hosomi;
    • Shunichi Sugawara;
    • Makoto Maemondo;
    • Tetsuya Okano;
    • Satoshi Morita;
    • Kotone Matsuyama;
    • Kunihiko Kobayashi;
    • Masahiro Seike
    Publication type:
    Article
    36

    Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

    Published in:
    2020
    By:
    • Shiraishi, Yoshimasa;
    • Kishimoto, Junji;
    • Tanaka, Kentaro;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirano, Katsuya;
    • Azuma, Koichi;
    • Hataji, Osamu;
    • Hayashi, Hidetoshi;
    • Tachihara, Motoko;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Okamoto, Isamu
    Publication type:
    journal article
    37
    38

    First‐line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non‐squamous non‐small cell lung cancer: Updated survival analysis of the ONO‐4538‐52/TASUKI‐52 randomized controlled trial.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 16, p. 17061, doi. 10.1002/cam4.6348
    By:
    • Kim, Hye Ryun;
    • Sugawara, Shunichi;
    • Lee, Jong‐Seok;
    • Kang, Jin‐Hyoung;
    • Inui, Naoki;
    • Hida, Toyoaki;
    • Lee, Ki Hyeong;
    • Yoshida, Tatsuya;
    • Tanaka, Hiroshi;
    • Yang, Cheng‐Ta;
    • Nishio, Makoto;
    • Ohe, Yuichiro;
    • Tamura, Tomohide;
    • Yamamoto, Nobuyuki;
    • Yu, Chong‐Jen;
    • Akamatsu, Hiroaki;
    • Takahashi, Shigeru;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    39

    Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase II trial (JMTO LC14‐01).

    Published in:
    Cancer Medicine, 2023, v. 12, n. 8, p. 9133, doi. 10.1002/cam4.5652
    By:
    • Takeuchi, Susumu;
    • Kubota, Kaoru;
    • Sugawara, Shunichi;
    • Teramukai, Satoshi;
    • Noro, Rintaro;
    • Fujikawa, Kei;
    • Hirose, Takashi;
    • Atagi, Shinji;
    • Minami, Seigo;
    • Iida, Shinichiro;
    • Kuraishi, Hiroshi;
    • Aiba, Tomoiki;
    • Minegishi, Yuji;
    • Matsumoto, Masaru;
    • Seike, Masahiro;
    • Gemma, Akihiko;
    • Kawahara, Masaaki
    Publication type:
    Article
    40
    41
    42

    Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer--data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).

    Published in:
    Japanese Journal of Clinical Oncology, 2015, v. 45, n. 7, p. 670, doi. 10.1093/jjco/hyv054
    By:
    • Eisaku Miyauchi;
    • Akira Inoue;
    • Kunihiko Kobayashi;
    • Makoto Maemondo;
    • Shunichi Sugawara;
    • Satoshi Oizumi;
    • Hiroshi Isobe;
    • Akihiko Gemma;
    • Yasuo Saijo;
    • Hirohisa Yoshizawa;
    • Koichi Hagiwara;
    • Toshihiro Nukiwa
    Publication type:
    Article
    43
    44
    45

    Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).

    Published in:
    Cancer Management & Research, 2021, v. 13, p. 9167, doi. 10.2147/CMAR.S336262
    By:
    • Tachihara, Motoko;
    • Tsujino, Kayoko;
    • Ishihara, Takeaki;
    • Hayashi, Hidetoshi;
    • Sato, Yuki;
    • Kurata, Takayasu;
    • Sugawara, Shunichi;
    • Okamoto, Isamu;
    • Teraoka, Shunsuke;
    • Azuma, Koichi;
    • Daga, Haruko;
    • Yamaguchi, Masafumi;
    • Kodaira, Takeshi;
    • Satouchi, Miyako;
    • Shimokawa, Mototsugu;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    46

    Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251318850
    By:
    • Tanzawa, Shigeru;
    • Yoshioka, Hiroshige;
    • Misumi, Toshihiro;
    • Miyauchi, Eisaku;
    • Ninomiya, Kiichiro;
    • Murata, Yasunori;
    • Takeshita, Masafumi;
    • Kinoshita, Fumihiko;
    • Fujishita, Takatoshi;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Hashimoto, Kazuki;
    • Mori, Masahide;
    • Miyanaga, Akihiko;
    • Hayashi, Anna;
    • Tanaka, Hisashi;
    • Honda, Ryoichi;
    • Nojiri, Masafumi;
    • Sato, Yuki;
    • Hata, Akito
    Publication type:
    Article
    47
    48

    Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.

    Published in:
    2016
    By:
    • Takeda, Masayuki;
    • Yamanaka, Takeharu;
    • Seto, Takashi;
    • Hayashi, Hidetoshi;
    • Azuma, Koichi;
    • Okada, Morihito;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirashima, Tomonori;
    • Yonesaka, Kimio;
    • Urata, Yoshiko;
    • Murakami, Haruyasu;
    • Saito, Haruhiro;
    • Kubo, Akihito;
    • Sawa, Toshiyuki;
    • Miyahara, Eiji;
    • Nogami, Naoyuki;
    • Nakagawa, Kazuhiko;
    • Nakanishi, Yoichi;
    • Okamoto, Isamu
    Publication type:
    journal article
    49
    50